The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Neuropathology of variants of progressive supranuclear palsy
Abstract
PURPOSE OF REVIEW: Neurodegenerative tauopathies, of which progressive supranuclear palsy (PSP) is one of the most common, are clinically heterogeneous, reflecting differences in distribution and biochemical composition of tau pathology. This review highlights the range of clinical and pathologic presentations of PSP and its variants. RECENT FINDINGS: Progressive supranuclear palsy is a 4R tauopathy with neuronal and glial tau-immunoreactive lesions in neuroanatomically specific nuclei in the basal ganglia, diencephalon, brainstem and cerebellum, with restricted involvement of the neocortex. Hierarchical cluster analyses of clinical and pathologic features of PSP indicate that there are distinct clinicopathologic variants of PSP. In variants of PSP presenting with focal cortical syndromes, such as frontotemporal dementia, corticobasal syndrome and apraxia of speech, there is greater cortical pathology than in typical PSP. In variants of PSP presenting with levodopa-responsive Parkinsonism, as well as pure akinesia and gait failure, there is less cortical pathology and more severe degeneration in the cardinal nuclei - globus pallidus, subthalamic nucleus and substantia nigra - than in typical PSP. SUMMARY: Clinical variants in PSP reflect varying anatomical distribution of tau pathology, but they share histopathologic, biochemical and genetic features with typical PSP. The basis for anatomical selective vulnerability in PSP and its variants remains to be determined.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The spatial distribution of this in vivo association between microglial activation and tau pathology in PSP mirrors previous findings showing that tau pathology affects not only subcortical but also cortical regions in PSP Richardson’s syndrome42,43.”
From Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy (2020) · cites this paper as [42]
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Lee, V. M.-Y., Goedert, M., & Trojanowski, J. Q. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1121 · Cited by 2,480
Progressive Supranuclear Palsy
Steele, J. C. (1964) · Archives of Neurology · doi:10.1001/archneur.1964.00460160003001 · Cited by 1,930
The `subcortical dementia' of progressive supranuclear palsy
Albert, M. L., Feldman, R. G., & Willis, A. L. (1974) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.37.2.121 · Cited by 871
Hauw, J., Daniel, S. E., Dickson, D. W., Horoupian, D. S., Jellinger, K. A., Lantos, P. L., McKee, A. C., Tabaton, M., & Litvan, I. (1994) · Neurology · doi:10.1212/wnl.44.11.2015 · Cited by 854
Self-citationAssociation of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Self-citationWilliams, D. R., de Silva, R., Paviour, D. C., Pittman, A. M., Watt, H., Kilford, L., Holton, J. L., Révész, T., & Lees, A. J. (2005) · Brain · doi:10.1093/brain/awh488 · Cited by 747
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech
Josephs, K. A. (2006) · Brain · doi:10.1093/brain/awl078 · Cited by 698
Self-citation
Cited by
Sorted by citations
Pathology of Neurodegenerative Diseases
Dugger, B. N., & Dickson, D. W. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028035 · Cited by 1,665
Self-citationParkinson's Disease and Parkinsonism: Neuropathology
Dickson, D. W. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009258 · Cited by 847
Self-citationParkinson's Disease and Parkinsonism
Hayes, M. T. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.03.001 · Cited by 823
The pathological process underlying Alzheimer’s disease in individuals under thirty
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609
Invited review: Neuropathology of tauopathies: principles and practice
Kovacs, G. G. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12208 · Cited by 492
Boxer, A. L., Yu, J.-T., Golbe, L. I., Litvan, I., Lang, A. E., & Höglinger, G. U. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30157-6 · Cited by 485
Distribution patterns of tau pathology in progressive supranuclear palsy
Kovacs, G. G., Lukic, M. J., Irwin, D. J., Arzberger, T., Respondek, G., Lee, E. B., Coughlin, D., Giese, A., Grossman, M., Kurz, C., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02158-2 · Cited by 483
Ahmed, Z., Cooper, J., Murray, T. K., Garn, K., McNaughton, E., Clarke, H., Parhizkar, S., Ward, M. A., Cavallini, A., Jackson, S., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1254-6 · Cited by 484
Self-citationAmyloid Polymorphism: Structural Basis and Neurobiological Relevance
Tycko, R. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.017 · Cited by 449
Astrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428
Neuropathology of Frontotemporal Lobar Degeneration-Tau (FTLD-Tau)
Dickson, D. W., Kouri, N., Murray, M. E., & Josephs, K. A. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9589-0 · Cited by 380
Self-citationMechanisms of secretion and spreading of pathological tau protein
Brunello, C. A., Merezhko, M., Uronen, R.-L., & Huttunen, H. J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03349-1 · Cited by 304
Boxer, A. L., Lang, A. E., Grossman, M., Knopman, D. S., Miller, B. L., Schneider, L. S., Doody, R. S., Lees, A., Golbe, L. I., Williams, D. R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70088-2 · Cited by 294
Phosphorylated α-Synuclein in Parkinson’s Disease
Wang, Y., Shi, M. Y., Chung, K. A., Zabetian, C. P., Leverenz, J. B., Berg, D., Srulijes, K., Trojanowski, J. Q., Lee, V. M. ‐., Siderowf, A. D., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002566 · Cited by 307
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?
Whitwell, J. L., Höglinger, G. U., Antonini, A., Bordelon, Y. M., Boxer, A. L., Colosimo, C., van Eimeren, T., Golbe, L. I., Kassubek, J., Kurz, C., et al. (2017) · Movement Disorders · doi:10.1002/mds.27038 · Cited by 263
Self-citationHonorat, J. A., Komorowski, L., Josephs, K. A., Fechner, K., Louis, E. K. S., Hinson, S. R., Lederer, S., Kumar, N., Gadoth, A., Lennon, V. A., et al. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000385 · Cited by 255
Self-citationSchöll, M., Maaß, A., Mattsson, N., Ashton, N. J., Blennow, K., Zetterberg, H., & Jagust, W. J. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.12.001 · Cited by 248
Ferrer, I., López-González, I., Carmona, M., Arregui, L., Dalfó, E., Torrejón-Escribano, B., Diehl, R., & Kovacs, G. G. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000030 · Cited by 217
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802395-2.00025-0 · Cited by 225
Cellular and pathological heterogeneity of primary tauopathies
Chung, D. C., Roemer, S. F., Petrucelli, L., & Dickson, D. W. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00476-x · Cited by 232
Self-citationTau in neurodegenerative disease
Gao, Y.-L., Wang, N., Sun, F.-R., Cao, X.-P., Zhang, W., & Yu, J.-T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.23 · Cited by 222
Lashley, T., Rohrer, J. D., Mead, S., & Révész, T. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12250 · Cited by 234
18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy
Passamonti, L., Rodríguez, P. V., Hong, Y. T., Allinson, K. S. J., Williamson, D., Borchert, R. J., Sami, S. A. K., Cope, T., Bevan-Jones, W. R., Jones, P. S., et al. (2016) · Brain · doi:10.1093/brain/aww340 · Cited by 210
Neurotransmitter deficits from frontotemporal lobar degeneration
Murley, A. G., & Rowe, J. B. (2017) · Brain · doi:10.1093/brain/awx327 · Cited by 211
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome
Jabbari, E., Holland, N., Chelban, V., Jones, P. S., Lamb, R., Rawlinson, C. V., Guo, T., Costantini, A. A., Tan, M. M. X., Heslegrave, A., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.4347 · Cited by 187
Schonhaut, D. R., McMillan, C. T., Spina, S., Dickerson, B. C., Siderowf, A., Devous, M. D., Tsai, R., Winer, J., Russell, D. S., Litvan, I., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25060 · Cited by 175
[ 18 F]FDG-PET is superior to [ 123 I]IBZM-SPECT for the differential diagnosis of parkinsonism
Hellwig, S., Amtage, F., Kreft, A., Buchert, R., Winz, O., Vach, W., Spehl, T. S., Rijntjes, M., Hellwig, B., Weiller, C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b0a · Cited by 175
Diagnostic Approach to Atypical Parkinsonian Syndromes
McFarland, N. R. (2016) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000348 · Cited by 179
Theory of Mind in normal ageing and neurodegenerative pathologies
Kemp, J., Després, O., Sellal, F., & Dufour, A. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.001 · Cited by 184
Respondek, G., Roeber, S., Kretzschmar, H. A., Troakes, C., Al‐Sarraj, S., Gelpí, E., Gaig, C., Chiu, W. Z., Swieten, J. C. V., Oertel, W. H., et al. (2013) · Movement Disorders · doi:10.1002/mds.25327 · Cited by 149
The Disturbance of Gaze in Progressive Supranuclear Palsy: Implications for Pathogenesis
Chen, A. L., Riley, D. E., King, S. A., Joshi, A. C., Serra, A., Liao, K., Cohen, M. L., Otero‐Millan, J., Martínez‐Conde, S., Strupp, M. L., et al. (2010) · Frontiers in Neurology · doi:10.3389/fneur.2010.00147 · Cited by 147
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
Forrest, S. L., Kril, J. J., Stevens, C. H., Kwok, J. B., Hallupp, M., Kim, W. S., Huang, Y. M., McGinley, C. V., Werka, H., Kiernan, M. C., et al. (2017) · Brain · doi:10.1093/brain/awx328 · Cited by 156
Dam, T., Boxer, A. L., Golbe, L. I., Höglinger, G. U., Morris, H. R., Litvan, I., Lang, A. E., Corvol, J., Aiba, I., Grundman, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01455-x · Cited by 152
Conserved brain myelination networks are altered in Alzheimer’s and other neurodegenerative diseases
Allen, M., Wang, X., Burgess, J. D., Watzlawik, J., Serie, D. J., Younkin, C. S., Nguyen, T., Malphrus, K. G., Lincoln, S., Carrasquillo, M. M., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.09.012 · Cited by 143
Self-citationDistinctive Features of Saccadic Intrusions and Microsaccades in Progressive Supranuclear Palsy
Otero‐Millan, J., Serra, A., Leigh, R. J., Troncoso, X. G., Macknik, S. L., & Martínez‐Conde, S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2600-10.2011 · Cited by 142
Boxer, A. L., Qureshi, I., Ahlijanian, M. K., Grundman, M., Golbe, L. I., Litvan, I., Honig, L. S., Tuite, P., McFarland, N. R., O’Suilleabhain, P. E., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30139-5 · Cited by 143
Roemer, S. F., Grinberg, L. T., Crary, J. F., Seeley, W. W., McKee, A. C., Kovács, G. G., Beach, T. G., Duyckaerts, C. J., Ferrer, I., Gelpí, E., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02479-4 · Cited by 130
Self-citationParkinsonism, movement disorders and genetics in frontotemporal dementia
Baizabal-Carvallo, J. F., & Jankovic, J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.14 · Cited by 121
Astroglia and Tau: New Perspectives
Kovacs, G. G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00096 · Cited by 115
Saccade Abnormalities in Autopsy-Confirmed Frontotemporal Lobar Degeneration and Alzheimer Disease
Garbutt, S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.1021 · Cited by 118
Glial Tau Pathology in Tauopathies: Functional Consequences
Kahlson, M. A., & Colodner, K. J. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25515 · Cited by 119
Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism
Scherfler, C., Göbel, G., Müller, C. F., Nocker, M., Wenning, G. K., Schocke, M. F. H., Poewe, W. H., & Seppi, K. (2016) · Neurology · doi:10.1212/wnl.0000000000002518 · Cited by 112
Progressive supranuclear palsy: Advances in diagnosis and management
Coughlin, D. G., & Litvan, I. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.04.014 · Cited by 118
α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease
Stuendl, A., Kraus, T., Chatterjee, M., Zapke, B., Sadowski, B., Moebius, W., Hobert, M. A., Deuschle, C., Brockmann, K., Maetzler, W., et al. (2021) · Movement Disorders · doi:10.1002/mds.28639 · Cited by 108
Intrinsic connectivity network disruption in progressive supranuclear palsy
Gardner, R. C., Boxer, A. L., Trujillo, A. J., Mirsky, J. B., Guo, C. C., Gennatas, E. D., Heuer, H. W., Fine, E. M., Zhou, J. H., Kramer, J. H., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23844 · Cited by 110
PET Imaging of Neuropathology in Tauopathies: Progressive Supranuclear Palsy
Kepe, V., Bordelon, Y., Boxer, A., Huang, S.-C., Liu, J., Thiede, F. C., Mazziotta, J. C., Mendez, M. F., Donoghue, N., Small, G. W., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130032 · Cited by 106
Treatment of Frontotemporal Dementia
Tsai, R. M., & Boxer, A. L. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-014-0319-0 · Cited by 115
Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease
Lipp, A., Trbojevic, R., Paul, F., Fehlner, A., Hirsch, S., Scheel, M., Noack, C., Braun, J., & Sack, I. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.09.006 · Cited by 100
Early-onset dementias: diagnostic and etiological considerations
Masellis, M., Sherborn, K., Rosa‐Neto, P., Sadovnick, A. D., Hsiung, G. R., Black, S. E., Prasad, S., Williams, M., & Gauthier, S. G. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt197 · Cited by 102
PERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration
Bell, M. C., Meier, S. E., Ingram, A., & Abisambra, J. F. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151218145431 · Cited by 104
Clinical Utility of 18F‐APN ‐1607 Tau PET Imaging in Patients with Progressive Supranuclear Palsy
Li, L., Liu, F., Li, M., Lu, J., Sun, Y., Liang, X., Bao, W., Chen, Q.-S., Li, X., Zhou, X., et al. (2021) · Movement Disorders · doi:10.1002/mds.28672 · Cited by 98
Tau-driven degeneration of sleep- and wake-regulating neurons in Alzheimer’s disease
Lew, C. H., Petersen, C., Neylan, T. C., & Grinberg, L. T. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101541 · Cited by 100
Advances in neuroimaging in frontotemporal dementia
Gordón, E., Rohrer, J. D., & Fox, N. C. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13656 · Cited by 104
Removing Protein Aggregates: The Role of Proteolysis in Neurodegeneration
Nijholt, D. A. T., Kimpe, L. D., Elfrink, H. L., Hoozemans, J. J. M., & Scheper, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795843236 · Cited by 96
Clinical Approach to Progressive Supranuclear Palsy
Ling, H. (2016) · Journal of Movement Disorders · doi:10.14802/jmd.15060 · Cited by 96
Progressive Supranuclear Palsy: an Update
Armstrong, M. J. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0819-5 · Cited by 95
Ling, H., de Silva, R., Massey, L. A., Courtney, R. J., Hondhamuni, G., Bajaj, N. P. S., Lowe, J. S., Holton, J. L., Lees, A. J., & Révész, T. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12037 · Cited by 97
Protein astrogliopathies in human neurodegenerative diseases and aging
Kovács, G. G., Lee, V. M., & Trojanowski, J. Q. (2017) · Brain Pathology · doi:10.1111/bpa.12536 · Cited by 93
Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants
Whitwell, J. L., Tosakulwong, N., Botha, H., Ali, F., Clark, H. M., Duffy, J. R., Utianski, R. L., Stevens, C. A., Weigand, S. D., Schwarz, C. G., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.102152 · Cited by 95
Self-citationA peculiar constellation of tau pathology defines a subset of dementia in the elderly
Kovács, G. G., Molnár, K., László, L., Ströbel, T., Botond, G., Hönigschnabl, S., Reiner‐Concin, A., Palkovits, M., Fischer, P. A., & Budka, H. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0819-x · Cited by 90
Milestones in atypical and secondary Parkinsonisms
Wenning, G. K., Litvan, I., & TOLOSA, E. S. (2011) · Movement Disorders · doi:10.1002/mds.23713 · Cited by 88
Progressive supranuclear palsy: progression and survival
Arena, J., Weigand, S. D., Whitwell, J. L., Hassan, A., Eggers, S. D. Z., Höglinger, G. U., Litvan, I., & Josephs, K. A. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7990-2 · Cited by 91
Self-citationNeuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy
Malpetti, M., Passamonti, L., Rittman, T., Jones, P. S., Vázquez Rodríguez, P., Bevan‐Jones, W. R., Hong, Y. T., Fryer, T. D., Aigbirhio, F. I., O'Brien, J. T., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25911 · Cited by 83
Garraux, G., Phillips, C. L. M., Schrouff, J., Kreisler, A., Lemaire, C. F., Degueldre, C., Delcour, C., Hustinx, R., Luxen, A., Destée, A., et al. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.06.004 · Cited by 83
Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy
Boelmans, K., Holst, B., Hackius, M., Finsterbusch, J., Gerloff, C., Fiehler, J., & Münchau, A. (2012) · Movement Disorders · doi:10.1002/mds.24926 · Cited by 80
Yoshida, K., Hata, Y., Kinoshita, K., Takashima, S., Tanaka, K., & Nishida, N. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1665-7 · Cited by 78
Identification of Conserved Proteomic Networks in Neurodegenerative Dementia
Swarup, V., Chang, T. S., Duong, D. M., Dammer, E. B., Dai, J., Lah, J. J., Johnson, E. C. B., Seyfried, N. T., Levey, A. I., & Geschwind, D. H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107807 · Cited by 78
Identification of conserved proteomic networks in neurodegenerative dementia
Swarup, V., Chang, T. S., Duong, D. M., Dammer, E. B., Lah, J. J., Johnson, E. E. C. B., Seyfried, N. T., Levey, A. I., & Geschwind, D. H. (2019) · doi:10.1101/825802 · Cited by 78
Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 DiseasePreprint
Serrano, G. E., Walkera, J., Arce, R., Glass, M. J., Vargas, D., Sue, L. I., Intorcia, A. J., Nelson, C. M., Oliver, J., Papa, J. D., et al. (2021) · medRxiv · doi:10.1101/2021.02.15.21251511 · Cited by 81
Self-citationGenetics of Progressive Supranuclear Palsy
Im, S. Y., Kim, Y. E., & Kim, Y. J. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15033 · Cited by 80
Ahmed, Z., Doherty, K. A., Silveira‐Moriyama, L., Bandopadhyay, R., Lashley, T., Mamais, A., Hondhamuni, G., Wray, S., Newcombe, J., O’Sullivan, S. S., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0857-4 · Cited by 79
Self-citationCerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP‐C
Koga, S., Josephs, K. A., Ogaki, K., Labbé, C., Uitti, R. J., Graff‐Radford, N. R., van Gerpen, J. A., Cheshire, W. P., Aoki, N., Rademakers, R., et al. (2016) · Movement Disorders · doi:10.1002/mds.26499 · Cited by 76
Self-citation[18F]‐THK5351 PET correlates with topology and symptom severity in progressive supranuclear palsy
Brendel, M., Schönecker, S., Höglinger, G., Lindner, S., Havla, J., Blautzik, J., Sauerbeck, J., Rohrer, G., Zach, C., Vettermann, F., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00440 · Cited by 72
Cellular and regional vulnerability in frontotemporal tauopathies
Forrest, S. L., Kril, J. J., & Halliday, G. M. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02035-7 · Cited by 74
FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants
Zalewski, N. L., Botha, H., Whitwell, J. L., Lowe, V. J., Dickson, D. W., & Josephs, K. A. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7256-4 · Cited by 71
Self-citationTau-induced pathology in epilepsy and dementia: notions from patients and animal models.
Sánchez, M., García-Cabrero, A., Sánchez-Elexpuru, G., Burgos, D., & Serratosa, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041092 · Cited by 68
CoQ10 in progressive supranuclear palsy
Apetauerova, D., Scala, S., Hamill, R. W., Simon, D. K., Pathak, S., Ruthazer, R., Standaert, D. G., & Yacoubian, T. A. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000266 · Cited by 68
Cognitive impairment in progressive supranuclear palsy is associated with tau burden
Koga, S., Parks, A. C., Kasanuki, K., Sánchez-Contreras, M., Baker, M., Josephs, K. A., Ahlskog, J. E., Uitti, R. J., Graff‐Radford, N. R., van Gerpen, J. A., et al. (2017) · Movement Disorders · doi:10.1002/mds.27198 · Cited by 67
Self-citationImpact of Tau on Neurovascular Pathology in Alzheimer's Disease
Canepa, E., & Fossati, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573324 · Cited by 67
Wallén‐Mackenzie, Å., Dumas, S., Papathanou, M., Martis, M. M., Vlcek, B., König, N., & Björklund, Å. K. (2020) · Communications Biology · doi:10.1038/s42003-020-1028-8 · Cited by 62
Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants
Lopez, G. J., Bayülkem, K., & Hallett, M. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12546 · Cited by 66
Sleepless Night and Day, the Plight of Progressive Supranuclear Palsy
Walsh, C. M., Yack, L. M., Walker, K., Emery, A., Varbel, J., Karageorgiou, E., Luong, P. N., Mance, I., Heuer, H. W., Boxer, A. L., et al. (2017) · SLEEP · doi:10.1093/sleep/zsx154 · Cited by 63
Dugger, B. N., Tu, M., Murray, M. E., & Dickson, D. W. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.020 · Cited by 61
Self-citationMidbrain atrophy is not a biomarker of progressive supranuclear palsy pathology
Whitwell, J. L., Jack, C. R., Parisi, J. E., Gunter, J. L., Weigand, S. D., Boeve, B. F., Ahlskog, J. E., Petersen, R. C., Dickson, D. W., & Josephs, K. A. (2013) · European Journal of Neurology · doi:10.1111/ene.12212 · Cited by 60
Self-citationCellular factors modulating the mechanism of tau protein aggregation
Fontaine, S. N., Sabbagh, J. J., Baker, J. D., Licha, C. R. M., Darling, A. L., & Dickey, C. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1839-9 · Cited by 66
Sleep Disorders in Atypical Parkinsonism
Abbott, S. M., & Videnović, A. (2014) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12025 · Cited by 59
Clinicopathologic subtype of Alzheimer's disease presenting as corticobasal syndrome
Sakae, N., Josephs, K. A., Litvan, I., Murray, M. E., Duara, R., Uitti, R. J., Wszołek, Z. K., van Gerpen, J. A., Graff‐Radford, N. R., & Dickson, D. W. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.04.011 · Cited by 66
Self-citationKobylecki, C., Jones, M. S., Thompson, J. C., Richardson, A. M. T., Neary, D., Mann, D. M. A., Snowden, J. S., & Gerhard, A. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7657-z · Cited by 59
Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease
Zanigni, S., Buonaura, G. C., Manners, D. N., Testa, C. M., Gibertoni, D., Evangelisti, S., Sambati, L., Guarino, M., Massis, P. D., Gramegna, L. L., et al. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.05.016 · Cited by 58
Heckman, M. G., Brennan, R. R., Labbé, C., Soto, A. I., Koga, S., Deture, M. A., Murray, M. E., Petersen, R. C., Boeve, B. F., van Gerpen, J. A., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0250 · Cited by 58
Self-citationPrevalence of progressive supranuclear palsy in Yonago: change throughout a decade
Takigawa, H., Kitayama, M., Wada‐Isoe, K., Kowa, H., & Nakashima, K. (2016) · Brain and Behavior · doi:10.1002/brb3.557 · Cited by 58
Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy
Whitwell, J. L., Duffy, J. R., Strand, E. A., Machulda, M. M., Senjem, M. L., Gunter, J. L., Kantarci, K., Eggers, S. D. Z., Jack, C. R., & Josephs, K. A. (2012) · European Journal of Neurology · doi:10.1111/ene.12004 · Cited by 60
Self-citationThree sib-pairs of autopsy-confirmed progressive supranuclear palsy
Fujioka, S., Sánchez-Contreras, M., Strongosky, A. J., Ogaki, K., Whaley, N. R., Tacik, P. M., van Gerpen, J. A., Uitti, R. J., Ross, O. A., Wszołek, Z. K., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.10.028 · Cited by 55
Self-citationNagao, S., Yokota, O., Nanba, R., Takata, H., Haraguchi, T., Ishizu, H., Ikeda, C., Takeda, N., Oshima, E., Sakane, K., et al. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.09.005 · Cited by 54
Jellinger, K. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02028-6 · Cited by 58
MRI Outperforms [18F]AV‐1451 PET as a Longitudinal Biomarker in Progressive Supranuclear Palsy
Whitwell, J. L., Tosakulwong, N., Schwarz, C. G., Botha, H., Senjem, M. L., Spychalla, A. J., Ahlskog, J. E., Knopman, D. S., Petersen, R. C., Jack, C. R., et al. (2018) · Movement Disorders · doi:10.1002/mds.27546 · Cited by 49
Self-citationFour-Repeat Tauopathies: Current Management and Future Treatments
VandeVrede, L. A., Ljubenkov, P. A., Rojas, J. C., Welch, A. E., & Boxer, A. L. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00888-5 · Cited by 55
Surova, Y., Nilsson, M., Lätt, J., Lampinen, B., Lindberg, O. E., Hall, S., Widner, H., Nilsson, C. F., van Westen, D., & Hansson, O. (2015) · Neuroradiology · doi:10.1007/s00234-015-1563-z · Cited by 49
Neuropathology of Sleep Disorders: A Review
Hauw, J., Hausser‐Hauw, C., Girolami, U. D., Hasboun, D., & Seilhean, D. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318211488e · Cited by 50
Metadata
- Authors
- Dickson, D. W., Ahmed, Z., Algom, A. A., Tsuboi, Y., & Josephs, K. A.
- Affiliations
- Mayo Clinic (US)
- UCL Queen Square Institute of Neurology (GB)
- Assaf Harofeh Medical Center (IL)
- Fukuoka University (JP)
- Corresponding author
- Dickson, Dennis W
- Venue
- Current Opinion in Neurology
- Published
- 2010-08
- Volume
- 23
- Issue
- 4
- Pages
- 394-400
- ISSN
- 1350-7540 (ISSN-L)
- OpenAlex
- W2085875718
- Cited by
- 386
- References
- 65
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 19 · 2023: 19 · 2022: 25 · 2021: 45 · 2020: 42 · 2019: 30 · 2018: 21 · 2017: 30 · 2016: 24 · 2015: 21 · 2014: 16 · 2013: 21 · 2012: 11
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Neurology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute on Aging (P50‐AG16574, P01AG017216, P50AG016574)
- National Institute of Neurological Disorders and Stroke (P50-NS40256, P50NS040256)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD049078, K12 HD 49078)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progressive supranuclear palsy, tauopathy, clinicopathological correlation, basal ganglia degeneration, levodopa-responsive parkinsonism, frontotemporal dementia, corticobasal syndrome, apraxia of speech, globus pallidus, subthalamic nucleus, substantia nigra, selective neuronal vulnerability
- MeSH terms
- Brain, Humans, Neurons, Phenotype, Supranuclear Palsy, Progressive, tau Proteins, Tauopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
